Table ST8 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

Table ST8 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

<p>Table ST8: Data output of the CCLE cell line screening provided by Prof. Schreiber at Broad Institute.</p>

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	Ossia M. Eichhoff (14964145) (author)
Tác giả khác:	Corinne I. Stoffel (14964148) (author), Jan Käsler (14964151) (author), Luzia Briker (14964154) (author), Patrick Turko (14964157) (author), Gergely Karsai (14964160) (author), Nina Zila (14964163) (author), Verena Paulitschke (14964166) (author), Phil F. Cheng (14940278) (author), Alexander Leitner (14964169) (author), Andrea Bileck (14964172) (author), Nicola Zamboni (14964175) (author), Anja Irmisch (14964178) (author), Zsolt Balazs (14964181) (author), Aizhan Tastanova (14964184) (author), Susana Pascoal (14964187) (author), Pål Johansen (14964190) (author), Rebekka Wegmann (6698010) (author), Julien Mena (14964193) (author), Alaa Othman (14964196) (author), Vasanthi S. Viswanathan (14964199) (author), Judith Wenzina (14964202) (author), Andrea Aloia (14964205) (author), Annalisa Saltari (14964208) (author), Andreas Dzung (14964211) (author), Michael Krauthammer (14964214) (author), Stuart L. Schreiber (14964217) (author), Thorsten Hornemann (14964220) (author), Martin Distel (14964223) (author), Berend Snijder (14964226) (author), Reinhard Dummer (14850772) (author), Mitchell P. Levesque (14964229) (author)
Được phát hành:	2025
Những chủ đề:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Reversal of drug resistance Metabolism Metabolomics Skin Cancers Melanoma Tumor Heterogeneity
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Table ST1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST4 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST5 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST7 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Table ST9 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Bằng: Ossia M. Eichhoff (14964145)
Được phát hành: (2025)

Figure S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Figure S2 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Figure S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Figure S4 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Figure S5 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Table S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Table S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
Bằng: Dahihm Kim (16546203)
Được phát hành: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
Bằng: Nicole A. Traphagen (16677391)
Được phát hành: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
Bằng: Nicole A. Traphagen (16677391)
Được phát hành: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Bằng: Yufang Bao (15386826)
Được phát hành: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Bằng: Yufang Bao (15386826)
Được phát hành: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Bằng: Yufang Bao (15386826)
Được phát hành: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Bằng: Yufang Bao (15386826)
Được phát hành: (2025)

Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Bằng: Yufang Bao (15386826)
Được phát hành: (2025)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Bằng: Alex C.H. Liu (14961921)
Được phát hành: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
Bằng: Phyllis S.Y. Chong (17141520)
Được phát hành: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
Bằng: Phyllis S.Y. Chong (17141520)
Được phát hành: (2025)

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Bằng: Laura E. Stevens (14961009)
Được phát hành: (2025)

Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
Bằng: Kavya Ramkumar (16474203)
Được phát hành: (2025)

Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Bằng: Jennifer L. Cotton (17315204)
Được phát hành: (2025)

Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
Bằng: Nina Müller (16721126)
Được phát hành: (2025)

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Bằng: Niklas Klümper (15048887)
Được phát hành: (2025)

Supplementary Data TS1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
Bằng: Niklas Klümper (15048887)
Được phát hành: (2025)

Supplementary Figure 8 from Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
Bằng: Seung Yeon Oh (15051017)
Được phát hành: (2025)

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Bằng: Laura E. Stevens (14961009)
Được phát hành: (2025)

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Bằng: Laura E. Stevens (14961009)
Được phát hành: (2025)

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Bằng: Laura E. Stevens (14961009)
Được phát hành: (2025)

Cannot write session to /tmp/vufind_sessions/sess_abq0fp2b2dbvl04bd2jitlrpik